4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-020703
Director sold 11,610 shares at $7.20 ($83,579)
- Director acquired 27,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dorval Allison Director | 2026-06-11 | Grant or award 10b5-1 | +27,000 | 102,390 | D | ||
| Dorval Allison Director | 2026-06-12 | Sale 10b5-1 | −11,610 | $7.20 | $83,579 | 90,780 | D |
| Open-market sales · 11,610 sh · avg $7.20 · $83,579 | |||||||
Loading xslF345X06/rdgdoc.xml…